Hakam Rajjoub

West Virginia University

Papers

1

Total Citations

4

H-Index

1

About

Hakam Rajjoub is a rising researcher in interventional pulmonology and thoracic surgery, whose work focuses on optimizing advanced treatments for chronic obstructive pulmonary disease (COPD) and emphysema. His most-cited paper, "Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States" (2025), directly compares two minimally invasive and surgical approaches for severe emphysema, offering critical insights into patient selection and outcomes. This work, already garnering 4 citations shortly after publication, highlights his ability to address pressing clinical questions in a rapidly evolving field. Rajjoub’s contributions lie in bridging gaps between procedural innovation and real-world application, particularly in evaluating the efficacy, safety, and cost-effectiveness of bronchoscopic lung volume reduction techniques. His research is instrumental for clinicians and trainees navigating the complex landscape of COPD management, where personalized therapy is paramount. As an emerging voice in pulmonary medicine, Rajjoub demonstrates a commitment to evidence-based practice and translational impact, making his work a valuable resource for students and researchers seeking to understand the future of interventional pulmonology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: West Virginia University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago